SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nektar Therapeutics (CA) Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain